News
May 23, 2023
OnKure Therapeutics Announces $54 Million Series C Financing
December 6, 2022
OnKure Therapeutics Appoints Robbie Alton, Pharm., as Vice President of Clinical Operations
June 21, 2022
OnKure Therapeutics Appoints Kevin S. Litwiler, Ph.D., as Senior Vice President of DMPK and Clinical Pharmacology
- View All News